Current AffairsWorld

Cuba begins clinical trials of its second COVID-19 vaccine

Havana: The Cuban regulatory agency has approved Phase 1 of clinical trials of the second Cuban vaccine against the novel coronavirus disease (COVID-19), Soberana 02, the vaccine’s developer, Finlay Institute, said on Twitter on Wednesday.

“We are pleased to inform you that Phase 1 of clinical trials of the Soberana 02 candidate vaccine, based on the Finlay Institute’s conjugated vaccine platform, has been approved by the centre for state control of drugs and medical equipment,” the institute said.

Clinical trials of the first Cuban vaccine, Soberana 01, began in August 2020 and will end in January 2021. The study involves 676 people aged 18 to 80.

Back to top button

Adblock Detected

Please consider supporting us by disabling your ad blocker